期刊文献+

晚期胃癌一线化疗的治疗进展 被引量:4

Treatment progress of first-line chemotherapy in gastric cancer
下载PDF
导出
摘要 胃癌是全球范围内癌症相关死亡的最常见原因之一。晚期胃癌患者进行化疗,能够缓解症状并获得生存益处。虽然目前尚无标准一线化疗方案推荐,但近年来一些新药的应用,为晚期胃癌的临床研究提供了新途径。本文就晚期胃癌一线化疗的治疗进展作一综述。 Gastric cancer is one of the most common causes of cancer-related death worldwide. Chemotherapy in patients with advanced stage of gastric cancer can relieve symptoms and obtain a survival benefit. Although there is no recommended suggestion of standard first-line chemotherapy, in recent years applications of new drugs provide a new way for advanced gastric cancer clinical research. In this paper, the progress of the nearest first-line treatment of advanced gastric cancer chemotherapy is reviewed.
出处 《中国实用医药》 2014年第8期254-256,共3页 China Practical Medicine
关键词 胃肿瘤 化学治疗 进展 Gastric cancer Chemotherapy Treatment progress
  • 相关文献

参考文献12

  • 1Okines A, Verheij M, Allum W, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2010,21(Suppl 5):v50-v54.
  • 2MacDonald JS, Schein PS, Woolley PV, et al. 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med, 1980,93(4): 533-536.
  • 3Ross P, Nicolson M, Cunningham D, et al. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubiein, cisplatin,and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 2002,20(8):1996- 2004.
  • 4Van Cutsem E, Moiseyenko VM, Tjulandin S, et al. Phase III study of docetaxel and eisplatin plus fluorouraeil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol, 2006,24(31):4991- 4997.
  • 5Van Cutsem E, Boni C, Tabernero J, et al. Randomized phase II study (GATE study) of docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer. J Clin Oncol, 2011,29 (Suppl 15):4018.
  • 6Inal A, Kaplan MA, Kucukoner M, Isikdogan A. Docetaxel and cisplatin plus fluorouracil compared with modified docetaxel, eisplatin, and 5-fluorouracil as first-line therapy for advanced gastric cancer: aretrospective analysis of single institution. Neoplasma, 2012,59(2):233-236.
  • 7Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for advanced esophagogastrie cancer. N Engl J Med, 2008,358:36- 46.
  • 8Al-Batran S-E, Hartmann JT, Probst S, et al. Phase Ⅲ trial in metastatic gastroesophageal adenocareinoma with fluorouraeil, leucovorin plus either oxaliplatin or eisplatin: a study of the Arbettsgemeinschaft Internistische Onkologie. J Clin Oneol, 2008, 26(9):1435-1442.
  • 9Dank M, Zaluski J, Barone C, et al. Randomized phase Ⅲ study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction. Ann Oncol, 2008,19(8): 1450-1457.
  • 10Kang YK, Kang WK, Shin DB, et al. Capecitabine/cisplat!n versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised Phase Ⅲ noninferiority trial. Ann Onco12009,20(4):666-673.

同被引文献27

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部